Latest Hemant Surgical Industries stock price
Hemant Surgical Industries P/E Ratio
HSIL • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
47.49
High Valuation
Very High - High growth expectations or significantly overvalued
Current Valuation Metrics
P/E Ratio
47.49
Current Price
₹
EPS (TTM)
₹7.70
Exchange
None
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
48.09
Sector Median
27.3
Sector Rank
#11 of 139
Sector Percentile
7.9%
Key P/E Ratio Insights for Hemant Surgical Industries
- Stock appears overvalued with PE of 47.49, suggesting caution for new investments
View the HSIL equity price for detailed stock performance.
Related Pages for Hemant Surgical Industries
Additional stock information and data for HSIL
Sector P/E Ratio Comparison
Comparing Hemant Surgical Industries with other companies in Healthcare sector
Sector Average
48.09
Sector Median
27.3
Lowest P/E
1.1
Highest P/E
754.17
Companies
139
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 1.1 | ₹38 | Low |
| Murae Organisor | MURAE | 3.14 | ₹47 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.87 | ₹1,186 | Low |
| Amwill Health Care | AMWILL | 6.5 | ₹67 | Low |
| Medicamen Organics | MEDIORG | 6.94 | ₹27 | Low |
| JFL Life Sciences | JFLLIFE | 7.53 | ₹36 | Low |
| Galaxy Medicare | GML | 7.66 | ₹26 | Low |
| Unichem Laboratories | UNICHEMLAB | 8.42 | ₹2,437 | Low |
| Zenith Drugs | ZENITHDRUG | 9.03 | ₹85 | Low |
| Brooks Laboratories | BROOKS | 9.44 | ₹198 | Low |